An Observational Study in an Urban Ugandan Clinic Comparing Virological Outcomes of Patients Switched From First-Line Antiretroviral Regimens to Second-Line Regimens Containing Ritonavir-Boosted Atazanavir or Ritonavir-Boosted Lopinavir
BMC Infectious Diseases - United Kingdom
doi 10.1186/s12879-019-3907-5
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 25, 2019
Authors
Publisher
Springer Science and Business Media LLC